PHILADELPHIA - (Business Wire) Lannett Company, Inc. (NYSE AMEX: LCI) today announced that it has received approvals from the U.S. Food and Drug Administration (FDA) of its Abbreviated New Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results